DarioHealthDRIO
DRIO
About: DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Employees: 202
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
21% more funds holding
Funds holding: 33 [Q3] → 40 (+7) [Q4]
6.41% less ownership
Funds ownership: 26.72% [Q3] → 20.32% (-6.41%) [Q4]
32% less capital invested
Capital invested by funds: $8.98M [Q3] → $6.1M (-$2.88M) [Q4]
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$2
167%
upside
Avg. target
$2
167%
upside
High target
$2
167%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Stifel David Grossman 44% 1-year accuracy 8 / 18 met price target | 167%upside $2 | Buy Maintained | 11 Mar 2025 |
Financial journalist opinion
Based on 4 articles about DRIO published over the past 30 days
Neutral
PRNewsWire
1 day ago
DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers
Strategic partnership expands Dario's employer footprint and has already started contributing to recurring revenues in Q1 of 2025 NEW YORK , April 17, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a new strategic partnership with a leading benefit administrator to deliver its comprehensive cardiometabolic solution including a GLP-1 support program and full AI-driven digital health suite to employers, with initial clients already implemented and contributing to revenue since January 2025. This marks Dario's first national benefit administrator partnership and represents a strategic step toward broader adoption across benefit administration channels.
Neutral
PRNewsWire
1 week ago
Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion
Second major healthcare employer signs with DarioHealth, accelerating growth in 2025 and reinforcing its leadership in AI-powered, clinically validated digital health solutions for chronic condition management NEW YORK , April 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a new employer partnership with one of the nation's most respected research and medical institutions. The signed agreement is already live and generating recurring revenue in 2025, marking a significant milestone in Dario's ongoing expansion among innovation-driven employers seeking measurable health outcomes and ROI.
Positive
Zacks Investment Research
3 weeks ago
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know
DarioHealth (DRIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Neutral
Business Wire
3 weeks ago
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth
NEW YORK--(BUSINESS WIRE)--Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO)* emerges as a potential hidden gem in digital health as competitor Hinge Health prepares to go public at a multi-billion-dollar valuation, highlighting a dramatic valuation gap that savvy investors are beginning to notice. With Hinge Health filing for a potential April IPO at a valuation that according to recent reports could reach $3-6 billion despite recent market volatility, DarioHealth's comprehensive AI.
Neutral
Seeking Alpha
1 month ago
DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Charles Rhyee - TD Cowen Ashok Kumar - ThinkEquity David Grossman - Stifel Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Fourth Quarter 2024 Results Conference Call. At this time, all lines are in listen-only mode.
Neutral
Business Wire
1 month ago
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue
NEW YORK--(BUSINESS WIRE)---- $DRIO #Biotech--Market News Alerts Updates: Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO) reported fourth quarter revenue of $7.6 million, beating analyst consensus of $7.39 million. B2B2C recurring revenue surged 398% year-over-year to $5.6 million in Q4, driven by rapid employer and health plan adoption of the company's comprehensive chronic care platform. Gross margins in the B2B2C business exceeded 80% over the past three quarters. Full-year 2024 revenue reached $2.
Neutral
PRNewsWire
1 month ago
DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results
Full-year 2024 revenue increased by 32.9% to $27.0 million from $20.4 million revenue in 2023. Revenue growth driven by B2B2C channel including employers and health plans resulting in recurring revenues which increased by 300% year over year as core business continues to gain traction.
Neutral
PRNewsWire
1 month ago
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula
The strategic arrangement fuels Dario's B2B2C sales growth, expanding access to over 15,000 providers nationwide NEW YORK , March 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a strategic collaboration with Rula Health, a leading provider of high-quality behavioral health services, to expand access to mental health support for employers and their workforce nationwide. Through this strategic collaboration, Dario clients will have access to Rula's extensive network of over 15,000 providers across the country with coverage of over 120 million commercial lives through most major insurance networks.
Neutral
PRNewsWire
1 month ago
Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth
Healthcare system collaborates with Dario to offer AI-powered chronic care management solutions as a benefit for their employee base of healthcare workers, expected to contribute to the current total of 15 new client signings in 2025, representing a significant head start in its 2025 net new client goal. NEW YORK , March 5, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today the signing of a contract with a major healthcare system to be added to its employer book of business, set to go live in the first quarter of 2025.
Neutral
PRNewsWire
1 month ago
DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025
Company to host conference call and webcast at 8:30am Eastern Time NEW YORK , March 4, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 4th quarter ended December 31 st, 2024 and will host a conference call and webcast at 8:30 am Eastern Time, on Monday, March 10 th, 2025, before the market opens. Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.
Charts implemented using Lightweight Charts™